logo-loader
viewConstellation Brands

Constellation Brands ups stake in Canopy Growth, invests an additional US$4bn

Constellation Brands CEO said he sees a 'tremendous growth' opportunity in the cannabis market

Corona bottles
The beverage company produces Corona and Modelo beers

Constellation Brands Inc (NYSE:STZ), the maker of Corona beer, is upping its investment in cannabis with a multi-billion dollar investment. The beer producer is investing US$4bn in Canadian cannabis company Canopy Growth Corp (NYSE:CGC, TSX:WEED).

Constellation’s latest investment brings its stake in the company to 38%. The company held a 9.9% stake in October 2017 with the option for future investments.

Shares of Canopy Growth jumped nearly 50% to US$36.48 in early trading on the news, reversing Tuesday's downward trend after posting less-than-stellar quarterly results.

READ: Canopy Growth reports quarterly earnings in-line with analyst expectations

"Over the past year, we've come to better understand the cannabis market, the tremendous growth opportunity it presents, and Canopy's market-leading capabilities in this space," said Constellation Brands CEO Rob Sands in a press release.

Constellation Brands shares fell more than 2% to US$216.50 in pre-market trading.

Quick facts: Constellation Brands

Price: 175.8 USD

NYSE:STZ
Market: NYSE
Market Cap: $33.9 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Antibe Therapeutics releases data from company’s Phase II placebo-controlled...

Antibe Therapeutics (CVE: ATE) CEO Dan Legault joined Steve Darling from Proactive Vancouver with new results from the company’s analysis of primary and secondary data from ATB-346’s recent placebo-controlled efficacy trial. Legault shares the data with Proactive and he also maps out the...

2 hours, 25 minutes ago

2 min read